Atlantic Investment Company’s Bristol-Myers Squibb BMY Stock Holding History

Atlantic Investment Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$670K	Buy	11,310 +245	+2%	+$15.5K	1.95%	18
2015 Q2	$736K	Hold	11,065	–	–	1.76%	16
2015 Q1	$714K	Hold	11,065	–	–	1.4%	18
2014 Q4	$653K	Buy	+11,065	New	+$624K	0.91%	20
2014 Q3	–	Sell	-11,195	Closed	-$559K	–	22
2014 Q2	$543K	Hold	11,195	–	–	0.47%	29
2014 Q1	$582K	Buy	11,195 +175	+2%	+$9.31K	0.57%	23
2013 Q4	$586K	Buy	11,020 +100	+0.9%	+$5.09K	0.52%	20
2013 Q3	$505K	Hold	10,920	–	–	0.33%	29
2013 Q2	$488K	Buy	+10,920	New	+$474K	0.36%	27

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Atlantic Investment Company's BMY Position: Q3 2015 in Review

Atlantic Investment Company increased its Bristol-Myers Squibb (BMY) stake by 2.2% in Q3 2015, buying an estimated $15.5K and bringing the position to 11,310 shares worth $670K. The position accounts for 1.95% of the portfolio, ranked #18.

Atlantic Investment Company first reported a position in BMY in Q2 2013 and has held it in 9 quarters since. The position peaked at $736K in Q2 2015. 1,453 funds tracked by Wall St. Rank hold BMY as of Q3 2015.

Atlantic Investment Company held 11,310 shares of Bristol-Myers Squibb worth $670K as of Q3 2015.
Atlantic Investment Company bought 245 Bristol-Myers Squibb shares in Q3 2015, an estimated $15.5K.
Bristol-Myers Squibb made up 1.95% of Atlantic Investment Company's portfolio in Q3 2015, its #18 holding.
Atlantic Investment Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 9 quarters since.
Atlantic Investment Company's Bristol-Myers Squibb position peaked at $736K in Q2 2015.
1,453 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2015.

Based on Atlantic Investment Company's 13F filing for Q3 2015, filed 13 Nov 2015.